NT5E and acute respiratory distress syndrome: Furthermore, interferon-beta treatment that up-regulates CD73, was associated with a reduction in mortality among patients with acute respiratory distress syndrome (ARDS), possibly by decreasing the pulmonary capillary permeability [13].